🚀 This week’s podcast covers a wide range of Biotech updates 🧬

Topics include a new gene-editing therapy used in a rare pediatric case, progress in cell sorting technologies, and recent patent activity in therapeutic development. If you’re looking for a brief, clear summary of what’s happening in the space, this episode offers a helpful overview.

🎧 Listen here. 

#Biotech #LifeSciences #GeneTherapy #CRISPR #Healthcare #IndustryUpdate #Podcast #AI #NotebookLM

Sources:

• Baby saved by gene-editing therapy 'graduates' from hospital, goes home
• STEMCELL Technologies Announces Acquisition of Cellular Highways
• Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds
• Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)
• Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.